Literature DB >> 11229623

The utilization of antidepressants in community-dwelling and institutionalized elderly--results form a representative survey in Germany.

S G Riedel-Heller1, H Matschinger, A Schork, M C Angermeyer.   

Abstract

Given its widespread occurrence and consequences, old-age depression has to be regarded as a major public health problem. Drug treatment has been proven effective in the majority of elderly individuals suffering from depression. This study presents pharmacoepidemiological data regarding the use of prescribed antidepressants and those purchased over the counter in the elderly. Furthermore, it links the data to simultaneously assessed depressive symptomatology. A representative survey on the utilization of prescription and over-the-counter antidepressant drugs and depressive symptomatology in community-dwelling (n = 1193) and institutionalized elderly individuals (n = 470) aged 75 and over was conducted in an urban region of Germany. Antidepressant use was found to be remarkably low (synthetic antidepressants: 2.2% of community dwelling individuals, 3.6% of institutionalized individuals; phytopharmaca containing hypericum perforatum: 4.2% of community dwelling individuals, 2.8% of institutionalized individuals). Two-thirds of the individuals treated with synthetic antidepressants received tri- and tetracyclic drugs, which were given at lower dosages than recommended for depression treatment. Selective serotonin reuptake inhibitors (SSRIs) were introduced in community-dwelling individuals only; none of the individuals cared for in residential and nursing homes received SSRIs. Only a minority of individuals with depressive symptoms were treated with antidepressants. The data suggests underutilization of antidepressants in the elderly, in which institutionalized elderly seem especially disadvantaged. The results call for increased efforts to discuss mental health issues in the public and to share scientific knowledge about symptoms, course and treatment options for depression. Furthermore, geronto-psychiatric competence of medical professionals, especially GPs, has to be systematically developed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229623     DOI: 10.1055/s-2001-15186

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  5 in total

1.  [Psychopharmacological drug treatment in Munich nursing homes].

Authors:  E Molter-Bock; J Hasford; T Pfundstein
Journal:  Z Gerontol Geriatr       Date:  2006-10       Impact factor: 1.281

2.  Characteristics and drug use patterns of older antidepressant initiators in Germany.

Authors:  Kathrin Jobski; Niklas Schmedt; Bianca Kollhorst; Jutta Krappweis; Tania Schink; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2016-10-18       Impact factor: 2.953

3.  Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims data.

Authors:  Christoph J Wagner; Charalabos Markos Dintsios; Florian G Metzger; Helmut L'Hoest; Ursula Marschall; Bjoern Stollenwerk; Stephanie Stock
Journal:  Int J Methods Psychiatr Res       Date:  2018-02-15       Impact factor: 4.035

Review 4.  Depression in nursing homes: ensuring adequate treatment.

Authors:  Robert H Llewellyn-Jones; John Snowdon
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data.

Authors:  Anke Bramesfeld; Thomas G Grobe; Friedrich Wilhelm Schwartz
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 12.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.